GeoVax Labs (GOVX) Non-Current Debt (2018 - 2021)
GeoVax Labs (GOVX) posted quarterly Non-Current Debt of $12157.0 for Q1 2021, down 50.94% year-over-year from $24781.0 in Q1 2020, and down 17.51% quarter-over-quarter from $14738.0 in Q4 2020.
GeoVax Labs (GOVX) Non-Current Debt (2018 - 2021) Analysis & Trends
GeoVax Labs (GOVX) has reported Non-Current Debt for 4 consecutive years, with $12157.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Non-Current Debt fell 50.94% year-over-year to $12157.0; the TTM figure through Mar 2021 stood at $12157.0 (down 50.94% YoY), while the FY2020 annual figure was $14738.0, down 45.9% from the prior year.
- Non-Current Debt fell to $12157.0 in Q1 2021 per GOVX's latest filing, from $14738.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $48958.0 in Q1 2018 and bottomed at $12157.0 in Q1 2021.
- Historically, Non-Current Debt has averaged $30236.5 across 4 years, with a median of $29167.0 in 2019.
- Annual changes were most pronounced in 2019 — Non-Current Debt decreased 27.66% — and 2021, when it plunged 50.94%.
- GeoVax Labs' Non-Current Debt stood at $39580.0 in 2018, then slumped by 31.17% to $27243.0 in 2019, then tumbled by 45.9% to $14738.0 in 2020, then declined by 17.51% to $12157.0 in 2021.
- Business Quant data shows GOVX's Non-Current Debt at $12157.0 in Q1 2021, $14738.0 in Q4 2020, and $18506.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 8.96 Bn |
| 10 | GeoVax Labs | 2.88 Mn | -267,341.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 12,157.00 |
| Dec 31, 2020 | 14,738.00 |
| Sep 30, 2020 | 18,506.00 |
| Jun 30, 2020 | 21,699.00 |
| Mar 31, 2020 | 24,781.00 |
| Dec 31, 2019 | 27,243.00 |
| Sep 30, 2019 | 29,167.00 |
| Jun 30, 2019 | 32,291.00 |
| Mar 31, 2019 | 35,417.00 |
| Dec 31, 2018 | 39,580.00 |
| Sep 30, 2018 | 42,706.00 |
| Jun 30, 2018 | 45,832.00 |
| Mar 31, 2018 | 48,958.00 |